Categories: News

Financière de Tubize – 2023 half-year financial report

Press release
29 July 2023

FINANCIERE DE TUBIZE SA

Allée de la Recherche 60, 1070 Brussels

Contact: Eric Nys, day-to-day management, eric.nys@financiere-tubize.be

2023 half-year financial report

Regulated information
29 July 2023

The board of directors of Financière de Tubize has issued the 2023 half-year financial report. This report is available on the website www.financiere-tubize.be

  • Profit for first half of 2023: € 91.1 million at 30 June 2023 (€ 87.3 million at 30 June 2022 (increase of 4.4%),
  • Dividend received from UCB: € 93.2 million (€ 1.33 per share, an increase of 2.3% compared to the previous year),
  • 2022 Dividend paid to Financière de Tubize’s shareholders in 2023 of € 38.3 million (€ 0.86 per share, an increase of  14.7% compared to the previous year),      
  • Acquisition, in 2023, of 649,750 UCB shares, for a total amount of € 52.0 million, at an average price of € 79.96, increasing the holding of the Company in UCB from 35.70% at 31 December 2022 to 36.04% at 30 June 2023.

Staff

Recent Posts

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

13 hours ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

16 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

16 hours ago

SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency

Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…

16 hours ago